Cargando…

Drug-induced Liver Injury Caused by Phenprobamate: Strong Probability Due to Repeated Toxicity

Drug-induced liver injury (DILI) is an important cause of morbidity and mortality. DILI can even cause acute liver failure and the need for liver transplantation. Identifying DILI may be particularly difficult because it is actually an exclusion diagnosis and individuals are usually exposed to sever...

Descripción completa

Detalles Bibliográficos
Autores principales: Duzenli, Tolga, Tanoglu, Alpaslan, Akyol, Taner, Kara, Muammer, Yazgan, Yusuf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Jaypee Brothers Medical Publishers 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6969320/
https://www.ncbi.nlm.nih.gov/pubmed/31988867
http://dx.doi.org/10.5005/jp-journals-10018-1295
_version_ 1783489304901713920
author Duzenli, Tolga
Tanoglu, Alpaslan
Akyol, Taner
Kara, Muammer
Yazgan, Yusuf
author_facet Duzenli, Tolga
Tanoglu, Alpaslan
Akyol, Taner
Kara, Muammer
Yazgan, Yusuf
author_sort Duzenli, Tolga
collection PubMed
description Drug-induced liver injury (DILI) is an important cause of morbidity and mortality. DILI can even cause acute liver failure and the need for liver transplantation. Identifying DILI may be particularly difficult because it is actually an exclusion diagnosis and individuals are usually exposed to several drugs during a lifetime. Causality assessment methods are needed for objective diagnosis. The most common methods are; updated Roussel Uclaf causality assessment method (RUCAM), Narenjo adverse drug reaction probability scale and Maria and Victorino (M&V) causality assessment scale. Phenprobamate is a widely used muscle relaxant. Herein we report a rare case of repeated DILI caused by phenprobamate and review the objective diagnostic process for hepatotoxicities. Physicians should be aware of the potential adverse effects of this drug, including hepatotoxicity. How to cite this article: Duzenli T, Tanoglu A, et al. Drug-induced Liver Injury Caused by Phenprobamate: Strong Probability Due to Repeated Toxicity. Euroasian J Hepatogastroenterol 2019;9(1) :49-51.
format Online
Article
Text
id pubmed-6969320
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Jaypee Brothers Medical Publishers
record_format MEDLINE/PubMed
spelling pubmed-69693202020-01-27 Drug-induced Liver Injury Caused by Phenprobamate: Strong Probability Due to Repeated Toxicity Duzenli, Tolga Tanoglu, Alpaslan Akyol, Taner Kara, Muammer Yazgan, Yusuf Euroasian J Hepatogastroenterol Case Report Drug-induced liver injury (DILI) is an important cause of morbidity and mortality. DILI can even cause acute liver failure and the need for liver transplantation. Identifying DILI may be particularly difficult because it is actually an exclusion diagnosis and individuals are usually exposed to several drugs during a lifetime. Causality assessment methods are needed for objective diagnosis. The most common methods are; updated Roussel Uclaf causality assessment method (RUCAM), Narenjo adverse drug reaction probability scale and Maria and Victorino (M&V) causality assessment scale. Phenprobamate is a widely used muscle relaxant. Herein we report a rare case of repeated DILI caused by phenprobamate and review the objective diagnostic process for hepatotoxicities. Physicians should be aware of the potential adverse effects of this drug, including hepatotoxicity. How to cite this article: Duzenli T, Tanoglu A, et al. Drug-induced Liver Injury Caused by Phenprobamate: Strong Probability Due to Repeated Toxicity. Euroasian J Hepatogastroenterol 2019;9(1) :49-51. Jaypee Brothers Medical Publishers 2019 /pmc/articles/PMC6969320/ /pubmed/31988867 http://dx.doi.org/10.5005/jp-journals-10018-1295 Text en Copyright © 2019; Jaypee Brothers Medical Publishers (P) Ltd. © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and non-commercial reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Duzenli, Tolga
Tanoglu, Alpaslan
Akyol, Taner
Kara, Muammer
Yazgan, Yusuf
Drug-induced Liver Injury Caused by Phenprobamate: Strong Probability Due to Repeated Toxicity
title Drug-induced Liver Injury Caused by Phenprobamate: Strong Probability Due to Repeated Toxicity
title_full Drug-induced Liver Injury Caused by Phenprobamate: Strong Probability Due to Repeated Toxicity
title_fullStr Drug-induced Liver Injury Caused by Phenprobamate: Strong Probability Due to Repeated Toxicity
title_full_unstemmed Drug-induced Liver Injury Caused by Phenprobamate: Strong Probability Due to Repeated Toxicity
title_short Drug-induced Liver Injury Caused by Phenprobamate: Strong Probability Due to Repeated Toxicity
title_sort drug-induced liver injury caused by phenprobamate: strong probability due to repeated toxicity
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6969320/
https://www.ncbi.nlm.nih.gov/pubmed/31988867
http://dx.doi.org/10.5005/jp-journals-10018-1295
work_keys_str_mv AT duzenlitolga druginducedliverinjurycausedbyphenprobamatestrongprobabilityduetorepeatedtoxicity
AT tanoglualpaslan druginducedliverinjurycausedbyphenprobamatestrongprobabilityduetorepeatedtoxicity
AT akyoltaner druginducedliverinjurycausedbyphenprobamatestrongprobabilityduetorepeatedtoxicity
AT karamuammer druginducedliverinjurycausedbyphenprobamatestrongprobabilityduetorepeatedtoxicity
AT yazganyusuf druginducedliverinjurycausedbyphenprobamatestrongprobabilityduetorepeatedtoxicity